Search results for "Protein microarray"

showing 3 items of 3 documents

Therapeutic and diagnostic applications of nanoparticles.

2011

Nanoparticles are sphere-like biocompatible materials made of inert silica, metal or crystals of a few nanometers in size. They are emerging as a novel class of therapeutics for cancer treatment. Being more selective and specific toward their targets, nanoparticles have the ability to enhance the anticancer effects and to simultaneously reduce systemic toxicity compared with conventional therapeutics. Furthermore, they offer the potential to overcome drug resistance leading to higher intracellular drug accumulation. Nowadays, nanotechnologies are applied to molecular diagnostics and incorporated in cutting-edge molecular diagnostic methods, such as DNA and protein microarray biochips. Nanot…

PharmacologyDrug Carriersbusiness.industryClinical BiochemistryMolecular Diagnostic MethodNanoparticleNanotechnologyAntineoplastic AgentsMolecular diagnosticsDrug accumulationBiocompatible materialMicroarray AnalysisDrug Delivery SystemsNanomedicineNeoplasmsDrug DiscoveryDrug deliveryProtein microarrayMolecular MedicineMedicineAnimalsHumansNanoparticlesbusinessBiochipCurrent drug targets
researchProduct

Proteomic Strategies and their Application in Cancer Research

2006

The understanding of carcinogenesis and tumor progression on a molecular basis needs a detailed study of proteins as effector molecules and as critical components of the multiple interconnected signaling pathways that drive the neoplastic phenotype. Thus, the proteomic approach represents a powerful tool for the challenge of the post-genomic era. The term “cancer proteome” refers to the collection of proteins expressed by a given cancer cell and should be considered as a highly dynamic entity within the cell, which affects a variety of cellular activities. The emerging proteomic analysis platforms including 2D-PAGE, mass spectrometry technologies, and protein microarrays represent powerful…

ProteomicsCancer ResearchBiomedical ResearchProtein Array AnalysisBiologyBioinformaticsProteomicsmedicine.disease_causeMass Spectrometry03 medical and health sciences0302 clinical medicineSettore BIO/13 - Biologia ApplicataNeoplasmsBiomarkers TumormedicineAnimalsHumansElectrophoresis Gel Two-DimensionalDrug discoveryCancerGeneral Medicinemedicine.diseasecancer proteomics protein microarray proteomics technologies tumor markers.OncologyTumor progression030220 oncology & carcinogenesisProteomeProtein microarrayCancer biomarkersCarcinogenesisTumori Journal
researchProduct

Proteomic Approaches in Colon Cancer: Promising Tools for New Cancer Markers and Drug Target Discovery

2005

Novel technologies are needed from which to identify new and more efficient biomarkers and improved molecular targets for the expedient and accurate diagnosis and treatment of colorectal cancer. Many advances have been made in direct and virtual imaging for detection of polyps and malignant-type lesions. These require tissue verification before definitive intervention. Inclusion of a simple serum test, more accurate than CEA, especially for early cancer detection, would make virtual imaging much more successful. Proteomics, the study of the proteins and protein pathways involved in disease, is a new dimension in preclinical and clinical development. Mass spectrometric analysis of serum prot…

ProteomicsNeovascularization PathologicColorectal cancerAngiogenesisbusiness.industryDrug targetProtein Array AnalysisGastroenterologyCancerDiseasemedicine.diseaseProteomicsBioinformaticsSensitivity and SpecificitySpecimen HandlingOncologyColonic NeoplasmsBiomarkers TumormedicineProtein microarrayHumansBiomarker (medicine)businessClinical Colorectal Cancer
researchProduct